| 0 (0%) | 10-16 08:20 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 11.79  |
1-year : | 14.74 |
| Resists | First : | 10.09 |
Second : | 12.61 |
| Pivot price | 8.05 |
|||
| Supports | First : | 6.01 | Second : | 5 |
| MAs | MA(5) : | 6.57 |
MA(20) : | 8.64 |
| MA(100) : | 11.35 |
MA(250) : | 13.96 |
|
| MACD | MACD : | -1.4 |
Signal : | -1.3 |
| %K %D | K(14,3) : | 6.5 |
D(3) : | 3.8 |
| RSI | RSI(14): 17.1 |
|||
| 52-week | High : | 20.57 | Low : | 6.01 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TNXP ] has closed above bottom band by 19.5%. Bollinger Bands are 68.1% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 7 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.7 - 6.72 | 6.72 - 6.75 |
| Low: | 6.21 - 6.24 | 6.24 - 6.27 |
| Close: | 6.37 - 6.41 | 6.41 - 6.46 |
Thu, 15 Oct 2026
TNXP 8-K & SEC Filings - Yahoo Finance
Wed, 14 Oct 2026
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP): What Does the Latest An Additional Managed Medicare Agreement Change? - Kalkine Media
Wed, 14 Oct 2026
Why TNXP Stock Is Suddenly Back On Retail Radar - Stocktwits
Wed, 14 Oct 2026
TNXP261016C00020000 Interactive Stock Chart | TNXP Oct 2026 20.000 call Stock - Yahoo Finance
Wed, 14 Oct 2026
TNXP Stock Dives For Four Straight Sessions — Retail Eyes Drug Pipeline Payoff - Stocktwits
Wed, 14 Oct 2026
TNXP Slips After Hours On Slower Than Expected Launch For Fibromyalgia Drug - Stocktwits
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 17 (M) |
| Shares Float | 14 (M) |
| Held by Insiders | 0.1 (%) |
| Held by Institutions | 55.9 (%) |
| Shares Short | 2,940 (K) |
| Shares Short P.Month | 3,100 (K) |
| EPS | -13.07 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 13.23 |
| Profit Margin | 0 % |
| Operating Margin | -314.1 % |
| Return on Assets (ttm) | -46.9 % |
| Return on Equity (ttm) | -81.9 % |
| Qtrly Rev. Growth | 577.9 % |
| Gross Profit (p.s.) | 1.42 |
| Sales Per Share | 1.69 |
| EBITDA (p.s.) | -9.53 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -153 (M) |
| Levered Free Cash Flow | -96 (M) |
| PE Ratio | -0.5 |
| PEG Ratio | 0 |
| Price to Book value | 0.48 |
| Price to Sales | 3.78 |
| Price to Cash Flow | -0.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|